0000891293-15-000011.txt : 20150324 0000891293-15-000011.hdr.sgml : 20150324 20150324172343 ACCESSION NUMBER: 0000891293-15-000011 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150320 FILED AS OF DATE: 20150324 DATE AS OF CHANGE: 20150324 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CTI BIOPHARMA CORP CENTRAL INDEX KEY: 0000891293 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911533912 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 2062827100 MAIL ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 FORMER COMPANY: FORMER CONFORMED NAME: CELL THERAPEUTICS INC DATE OF NAME CHANGE: 19960321 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SINGER JACK W CENTRAL INDEX KEY: 0001204264 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12465 FILM NUMBER: 15722619 MAIL ADDRESS: STREET 1: 501 ELLIOT AVENUE WEST STREET 2: SUITE 400 CITY: SEATTLE STATE: WA ZIP: 98119 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2015-03-20 0 0000891293 CTI BIOPHARMA CORP CTIC 0001204264 SINGER JACK W 3101 WESTERN AVE SUITE 600 SEATTLE WA 98121 1 1 0 0 EVP, Global Medical Affairs Common Stock 2015-03-20 4 S 0 6700 1.92 D 1490789 D Common Stock 2015-03-20 4 S 0 16200 1.93 D 1474589 D Common Stock 2015-03-20 4 S 0 18600 1.94 D 1455989 D Common Stock 2015-03-20 4 S 0 2900 1.943 D 1453089 D Common Stock 2015-03-20 4 S 0 19600 1.95 D 1433489 D Common Stock 2015-03-20 4 S 0 3600 1.96 D 1429889 D Common Stock 2015-03-21 4 F 0 93970 1.935 D 1335919 D The sale was effected pursuant to a rule 10b5-1 trading plan. Represents shares withheld by CTIC to satisfy tax withholding obligations on the vesting of restricted stock. By: Louis A. Bianco, Attorney-in-fact For: Jack Singer 2015-03-24